🎉 M&A multiples are live!
Check it out!

Asymchem Laboratories Valuation Multiples

Discover revenue and EBITDA valuation multiples for Asymchem Laboratories and similar public comparables like Suven Pharma, Biocon, and Syngene International.

Asymchem Laboratories Overview

About Asymchem Laboratories

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.


Founded

1998

HQ

China
Employees

9.8K+

Website

asymchem.com

Financials

LTM Revenue $831M

LTM EBITDA $181M

EV

$2.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Asymchem Laboratories Financials

Asymchem Laboratories has a last 12-month revenue of $831M and a last 12-month EBITDA of $181M.

In the most recent fiscal year, Asymchem Laboratories achieved revenue of $800M and an EBITDA of $218M.

Asymchem Laboratories expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Asymchem Laboratories valuation multiples based on analyst estimates

Asymchem Laboratories P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.1B $800M XXX XXX XXX
Gross Profit $669M $552M XXX XXX XXX
Gross Margin 62% 69% XXX XXX XXX
EBITDA $417M $218M XXX XXX XXX
EBITDA Margin 39% 27% XXX XXX XXX
Net Profit $455M $313M XXX XXX XXX
Net Margin 42% 39% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Asymchem Laboratories Stock Performance

As of April 15, 2025, Asymchem Laboratories's stock price is CNY 63 (or $9).

Asymchem Laboratories has current market cap of CNY 22.9B (or $3.2B), and EV of CNY 15.9B (or $2.2B).

See Asymchem Laboratories trading valuation data

Asymchem Laboratories Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.2B $3.2B XXX XXX XXX XXX $0.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Asymchem Laboratories Valuation Multiples

As of April 15, 2025, Asymchem Laboratories has market cap of $3.2B and EV of $2.2B.

Asymchem Laboratories's trades at 2.6x LTM EV/Revenue multiple, and 12.1x LTM EBITDA.

Analysts estimate Asymchem Laboratories's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Asymchem Laboratories and 10K+ public comps

Asymchem Laboratories Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $2.2B XXX XXX XXX
EV/Revenue 2.7x XXX XXX XXX
EV/EBITDA 10.0x XXX XXX XXX
P/E 24.1x XXX XXX XXX
P/E/Growth 1.4x XXX XXX XXX
EV/FCF 127.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Asymchem Laboratories Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Asymchem Laboratories Valuation Multiples

Asymchem Laboratories's NTM/LTM revenue growth is 14%

Asymchem Laboratories's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $25K for the same period.

Over next 12 months, Asymchem Laboratories's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Asymchem Laboratories's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Asymchem Laboratories and other 10K+ public comps

Asymchem Laboratories Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -26% XXX XXX XXX XXX
EBITDA Margin 27% XXX XXX XXX XXX
EBITDA Growth -48% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 41% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $25K XXX XXX XXX XXX
S&M Expenses to Revenue 2% XXX XXX XXX XXX
G&A Expenses to Revenue 4% XXX XXX XXX XXX
R&D Expenses to Revenue 11% XXX XXX XXX XXX
Opex to Revenue 30% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Asymchem Laboratories Public Comps

See public comps and valuation multiples for Contract Research & Manufacturing and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Jubilant Pharmova XXX XXX XXX XXX XXX XXX
Biocon XXX XXX XXX XXX XXX XXX
Syngene International XXX XXX XXX XXX XXX XXX
Dishman Carbogen Amics XXX XXX XXX XXX XXX XXX
Suven Pharma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Asymchem Laboratories M&A and Investment Activity

Asymchem Laboratories acquired  XXX companies to date.

Last acquisition by Asymchem Laboratories was  XXXXXXXX, XXXXX XXXXX XXXXXX . Asymchem Laboratories acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Asymchem Laboratories

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Asymchem Laboratories

When was Asymchem Laboratories founded? Asymchem Laboratories was founded in 1998.
Where is Asymchem Laboratories headquartered? Asymchem Laboratories is headquartered in China.
How many employees does Asymchem Laboratories have? As of today, Asymchem Laboratories has 9.8K+ employees.
Who is the CEO of Asymchem Laboratories? Asymchem Laboratories's CEO is Dr. Hao Hong.
Is Asymchem Laboratories publicy listed? Yes, Asymchem Laboratories is a public company listed on SHE.
What is the stock symbol of Asymchem Laboratories? Asymchem Laboratories trades under 002821 ticker.
When did Asymchem Laboratories go public? Asymchem Laboratories went public in 2016.
Who are competitors of Asymchem Laboratories? Similar companies to Asymchem Laboratories include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics.
What is the current market cap of Asymchem Laboratories? Asymchem Laboratories's current market cap is $3.2B
What is the current revenue of Asymchem Laboratories? Asymchem Laboratories's last 12-month revenue is $831M.
What is the current EBITDA of Asymchem Laboratories? Asymchem Laboratories's last 12-month EBITDA is $181M.
What is the current EV/Revenue multiple of Asymchem Laboratories? Current revenue multiple of Asymchem Laboratories is 2.6x.
What is the current EV/EBITDA multiple of Asymchem Laboratories? Current EBITDA multiple of Asymchem Laboratories is 12.1x.
What is the current revenue growth of Asymchem Laboratories? Asymchem Laboratories revenue growth between 2023 and 2024 was -26%.
Is Asymchem Laboratories profitable? Yes, Asymchem Laboratories is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.